Actively Recruiting
Spanish Registry for Autoimmune and Cholestatic Liver Diseases including PBC, HAI, PSC, and Genetic Cholestatic Conditions
Led by Asociación Española para el Estudio del Hígado · Updated on 2025-01-10
5000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This observational study aims to understand the current status of several liver diseases in Spain, including primary biliary cholangitis, autoimmune hepatitis, primary sclerosing cholangitis, and genetic cholestatic diseases. The study is sponsored by the Asociacin Espaola para el Estudio del Hgado and focuses on collecting detailed information about these conditions within the Spanish population. Participants included in this registry have confirmed diagnoses of the liver diseases mentioned. The study collects data from 2016 through 2030, tracking how common these diseases are, the characteristics of affected patients, the development of liver-related health events, and treatments used during this period. Participants will provide information about their liver condition, which will be used to monitor disease prevalence, progression, and treatment patterns. The main outcome measured is the prevalence and features of these liver diseases by 2025. Secondary outcomes include tracking liver-related events and treatments from 2016 to 2030. Participants remain in the study through this period, contributing data to help researchers better understand these diseases in Spain.
CONDITIONS
Brief Title
Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)
Research Team
A
Asociación Española para el Estudio del Hígado Asociación Espa
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
